CD4 Lymphocyte CountAntigens, CD8Antigens, CD3CD40 LigandAntigens, CD34Antigens, CD40CD4-CD8 RatioAntigens, CD44Antigens, CD28HIV InfectionsCD4-Positive T-LymphocytesAntigens, CD14Antigens, CD38Anti-HIV AgentsAntiretroviral Therapy, Highly ActiveAntigens, CD1Antigens, CD80Antigens, CD2Viral LoadAntigens, CD19Antigens, CD86Antigens, CD95Antigens, CD5Antigens, CDAntigens, CD18Antigens, CD56Antigens, CD30Anti-Retroviral AgentsAntigens, CD24Antigens, CD36Antigens, CD9HIV-1AIDS-Related Opportunistic InfectionsAntigens, CD20Antigens, CD7Antigens, CD43CD8-Positive T-LymphocytesAntigens, CD11Antigens, CD47Antigens, CD59Antigens, CD70Antigens, CD46South AfricaAntigens, CD11bAntigens, CD57Treatment OutcomeAntigens, CD81Antigens, CD137Antigens, CD31CD30 LigandAntigens, CD11cAntigens, CD151Antigens, CD55Antigens, CD58Antigens, CD63Cohort StudiesAntigens, CD13Antigens, CD11aRetrospective StudiesProspective StudiesRNA, ViralUgandaLost to Follow-UpTime FactorsImmunophenotypingAcquired Immunodeficiency SyndromeAntigens, CD147Cote d'IvoireHIVAntigens, CD82Follow-Up StudiesLymphoma, AIDS-RelatedCoinfectionMeningitis, CryptococcalDrug Therapy, CombinationDrug Resistance, ViralAntigens, CD274Drug Administration ScheduleBenzoxazinesHematopoietic Stem Cell MobilizationDideoxynucleosidesAntigens, CD146Survival AnalysisDidanosineZidovudineTuberculosisRisk FactorsFlow CytometryImmunologic MemoryNevirapineHIV SeropositivityDendritic CellsLamivudineRitonavirTreatment FailureAntigens, Differentiation, T-LymphocyteAntigens, CD15Antigens, CD79T-Lymphocytes, RegulatoryZimbabwe